INmune Bio

+$0.16 (+2.59%) Today

$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INmune Bio and other ETFs, options, and stocks.

About INMB

INmune Bio, Inc. Is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprograms the immune system to fight cancer and Alzheimer’s disease.

CEO

Raymond J. Tesi

Employees

Headquarters

Boca Raton, Florida

Founded

2015

INMB Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

—

Average volume

227.78K

High today

$6.43

Low today

$6.05

Open price

$6.09

Volume

204.49K

52 Week high

$30.37

52 Week low

$4.63

INMB News

MarketWatchMay 24

INmune Bio stock plunges after clinical hold of IND of Alzheimer's treatment prompts analyst downgrade

Shares of INmune Bio Inc. INMB, -1.09% plummeted 31.4% toward a 22-month low in premarket trading Tuesday, after the Florida-based biotechnology company said it

INMB Earnings

-$0.64

-$0.43

-$0.21

$0.00

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Estimated

— per share

Actual

Expected Aug 3, After Hours

Why Robinhood?

INmune Bio, Inc. Is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprograms the immune system to fight cancer and Alzheimer’s disease. View more

INmune Bio stock plunges after clinical hold of IND of Alzheimer's treatment prompts analyst downgrade

INmune Bio, Inc. Is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprograms the immune system to fight cancer and Alzheimer’s disease.